Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A single-case report from an ongoing Phase Ib trial describing one patient's response; while the outcome is noteworthy, case reports lack comparison groups and generalizability to support clinical practice change.
A narratively synthesized review proposing a clinical implementation framework for RSV vaccination in cardiovascular disease, grounded in trial evidence for respiratory but not cardiovascular endpoints.
A controlled animal study of sound design showing clinical benefit (reduced diarrhea, improved growth) and coordinated immune responses, but limited by single-species testing, surrogate endpoints, and absence of efficacy statistics for the primary comparisons.
Small single-site controlled animal study with surrogate immunological endpoints and no clinical disease observed; provides mechanistic insight into PCV3 vaccine response but lacks power and clinical outcome data needed for efficacy claims.